UbiVac
@UbiVac
Followers
379
Following
880
Statuses
1K
UbiVac is a clinical stage biotech engaged in research and development and manufacture of therapeutic immune activators, vaccines and cellular immunotherapies
Portland, OR
Joined May 2012
Thrilled that @UbiVac ‘s DPV-001, the 1st #DarkMatter #cancer #Immunotherapy in the clinic, is improving response rate & progression-free survival for patients with head & neck squamous cell cancer #HNSCC / @incyte Today #SITC2024 poster #1481
0
0
1
RT @BernardAFox: Appreciate @oncodaily publishing LinkedIn post highlighting world’s 1st cancer’s #DarkMatter #immunotherapy! This strateg…
0
6
0
RT @NatureRevCancer: #REVIEW 🚨 Hanahan, Michielin & Pittet discuss how, nearly all cell types in the tumour microenvironment can be progr…
0
30
0
RT @ZEROCancer: 🚨 BREAKING: Sens. @CoryBooker & @JohnBoozman introduce bipartisan PSA Screening for HIM Act (S. 297)! This bill would elim…
0
4
0
RT @PennMedicine: CAR T cells have cured cancer for many patients. But the current treatment process is a laborious (and expensive) one. Th…
0
24
0
RT @rbryanbell: RIP President Carter. Diagnosed with metastatic melanoma in 2015, he was declared cancer-free a few months later thanks to…
0
3
0
RT @OmidHamidMD: #SITC24 @BernardAFox recognized with well deserved @sitcancer lifetime achievement award. A strong leader and friend. Be…
0
12
0
RT @BernardAFox: 💥 #Cancer #Vaccines in combo IO are #HOT!! See @romleidner at noon today Poster #1481 #SITC2024 /56% RR in PD-1 naïve & 33…
0
4
0
RT @parkerici: #Glioblastoma (GBM) is one of the most difficult cancers to treat, in part due to its immunosuppressive tumor microenvironme…
0
13
0
RT @DrORourke2: This is a massive overreach - AI driven discovery does not account for biological complexity which is the major challenge i…
0
1
0
RT @DrORourke2: Our group recently also showed that TGFb disruption enhanced our bivalent CART cell approach currently in P1 for recurrent…
0
2
0
RT @ChilesResearch: Best wishes to @RachelSanbornMD as she heads to @ESMO Congress 2024. She will be giving an oral presentation on her abs…
0
1
0
RT @ChilesResearch: After 31 years of extraordinary cancer leadership, Providence Cancer Institute CMO @WalterUrba will retire at the end o…
0
5
0
RT @ChilesResearch: We're cheering on all the teams participating in this weekend’s #HoodtoCoast including the amazing Cancer Crushers, a t…
0
1
0
RT @rbryanbell: Honored to join this morning the indefatigable @roth_becky at @KATUNews for AM Northwest to discuss cancer research @provid…
0
3
0
RT @ChilesResearch: On our blog: In special Q & A to honor #WorldPatientAdvocacyDay cancer survivor & patient advocate @MarkstageIV speaks…
0
2
0
RT @ChilesResearch: It's #WorldBreastCancerResearchDay recognizing past, present & future life-changing research to end #breastcancer. @ses…
0
2
0
RT @Jasonmmast: Vir Biotechnology announced today it's all but abandoning infectious disease research and pivoting to cancer. My story fr…
0
20
0
RT @DrMvandenBrink: FDA Approves CAR T Cell Treatment for Resistant Mantle Cell Lymphoma | Memorial Sloan Kettering Cancer Center https://t…
0
4
0
RT @JennGuerriero: Please repost! First time attendees to the @sitcancer annual meeting from Latin America receive significantly discounted…
0
17
0